 |
Indication & Dosage |
| |
| |
| Intramuscular |
| AS ANABOLIC AFTER DEBILITATING ILLNESS |
| Adult:
As decanoate: 25-100 mg once every 3-4 wk. |
| |
| Intramuscular |
| POSTMENOPAUSAL OSTEOPOROSIS |
| Adult:
As decanoate: 25-100 mg once every 3-4 wk. |
| |
| Intramuscular |
| METASTATIC BREAST CARCINOMA |
| Adult:
As decanoate: 25-100 mg once every 3-4 wk |
| |
| Intramuscular |
| ANAEMIA OF CHRONIC RENAL FAILURE |
| Adult:
As decanoate: 50-200 mg wkly. |
| |
| Intramuscular |
| ANAEMIA IN CHEMOTHERAPY PATIENTS |
| Adult:
50-150 mg wkly |
|
| |
|
| Precautions |
Monitor diabetic patients carefully. Conditions influenced by oedema (e.g. CV disease, migraine, seizure disorder, renal impairment). Hepatic impairment. Elderly. Discontinue if signs of virilisation in women occur. Monitor skeletal maturation in children. |
| |
|
Potentially Life-threatening
Adverse Drug Reactions |
May increase effects of oral anticoagulants, insulin, oral antidiabetic agents, adrenal steroid, adrenocorticotropic hormone (ACTH). |
| |
|
| Adverse Drug Reactions |
Male: Postpubertal: Acne, gynaecomastia, bladder irritability, priapism, insomnia, chills, decreased libido, hepatic dysfunction, nausea, diarrhoea, prostatic hyperplasia. Prepubertal: Acne, virilism, chills, insomnia, hyperpigmentation, diarrhoea, nausea. Female: Virilism, hypercalcaemia, nausea, diarrhoea, chills, insomnia, iron deficiency anaemia, hepatic dysfunction. |
| |
|
|
|
